April 11, 2018 05:32 PM EDTUpdated 05:47 PM

Vivek Ramaswamy is diving into RNA, launching a new biotech with Arbutus and a team of vets

After buying up a big chunk of Arbutus’ $ABUS shares, Roivant CEO Vivek Ramaswamy has created a new joint venture startup that brings some top …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vivek Ra­maswamy is div­ing in­to RNA, launch­ing a new biotech with Ar­bu­tus and a team of vets